Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4767916

O=C(Nc1ccc2c(c1)CCN(C1CCC1)CC2)c1ccc2ccccc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS2 O15393 2/20 0.55
SLC2A1 P11166 1/20 0.50
PLAU P00749 1/20 0.48
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
MCL1 Q07820 1/20 0.47
NFKB1 P19838 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
HTT P42858 2/20 0.47
TP53 P04637 2/20 0.47
GAA P10253 1/20 0.47
HRH3 Q9Y5N1 4/20 0.47
TRPV1 Q8NER1 1/20 0.46
DEGS1 O15121 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774628 0.93 TMPRSS2 (0.61) TMPRSS2PLAUNPC1RAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4767622 0.89 HRH3 (0.51) TMPRSS2SLC2A1PLAUNPC1RAB9A
Trifluoroacetic Acid SCHEMBL4765533 0.88 HRH3 (0.61) SLC2A1NPC1RAB9ASMN1; SMN2NFKB1
Trifluoroacetic Acid SCHEMBL4774309 0.87 ABCB1 (0.50) SLC2A1NPC1RAB9ASMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL4774281 0.86 SLC2A1 (0.58) SLC2A1NPC1RAB9ASMN1; SMN2KMT2A
Trifluoroacetic Acid SCHEMBL4772660 0.86 ESR1 (0.50) SLC2A1PLAUNPC1RAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4770267 0.86 HRH3 (0.57) TMPRSS2SLC2A1NPC1RAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4768268 0.85 SLC2A1 (0.47) SLC2A1PLAUNPC1RAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4775559 0.85 SLC2A1 (0.47) TMPRSS2SLC2A1PLAUNPC1RAB9A
Trifluoroacetic Acid SCHEMBL4775421 0.85 KCNK3 (0.51) SLC2A1NPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 TMPRSS2 1089/4885SLC2A1 4665/4885PLAU 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.